SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001493152-23-009347
Filing Date
2023-03-28
Accepted
2023-03-28 20:00:17
Documents
2
Period of Report
2023-03-24

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 1572
2 ex24.htm EX-24 8414
  Complete submission text file 0001493152-23-009347.txt   11444
Mailing Address 1055 WESTLAKES DRIVE, SUITE 300 BERWYN PA 19312
Business Address 1055 WESTLAKES DRIVE, SUITE 300 BERWYN PA 19312 610-727-4597
Virpax Pharmaceuticals, Inc. (Issuer) CIK: 0001708331 (see all company filings)

IRS No.: 821510982 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O VIRPAX PHARMACEUTICALS, INC. 1055 WESTLAKES DRIVE, SUITE 300 BERWYN PA 19312
Business Address
Ruskin Barbara (Reporting) CIK: 0001969041 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40064 | Film No.: 23771414